Niagen Bioscience, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $22.2M | $68.3M | $44.5M |
| FY2025 | $29.9M | $106.4M | $64.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $22.2M | $68.3M | $44.5M |
| FY2025 | $29.9M | $106.4M | $64.8M |